Submitted by Anonymous (not verified) on 19 November 2026 - 9:31
Orphan designation: zolacabtagene autoleucel Treatment of PLN R14del cardiomyopathy, 20/08/2026 Positive
Source:
Orphan designation: zolacabtagene autoleucel Treatment of PLN R14del cardiomyopathy, 20/08/2026 Positive